Latest

Alnylam Launches AMVUTTRA Awareness Initiative to Highlight Earlier ATTR-CM Diagnosis Alnylam Pharmaceuticals has launched a new U.S. educational initiative called

Alnylam Pharmaceuticals has launched a new U.S. educational initiative called “Play by Play” to raise awareness of transthyretin amyloid cardiomyopathy, or ATTR-CM, and encourage...

09-29-26

L3Harris Wins $6 Billion THAAD Propulsion Contract to Expand Missile Defense Production L3Harris Technologies has received an undefinitized contract from

L3Harris Technologies has received an undefinitized contract from Lockheed Martin valued at more than $6 billion over seven years to significantly expand propulsion production...

09-29-26

Ford, JPMorganChase and Michigan Launch $2 Billion Industrial Growth Initiative Ford Motor Company, JPMorganChase, the State of Michigan, Michigan Central

Ford Motor Company, JPMorganChase, the State of Michigan, Michigan Central and Newlab have launched Michigan LIFT, a public-private initiative designed to accelerate manufacturing innovation,...

09-29-26

Corteva and Inari Reach Settlement in Seed Technology Lawsuit Corteva and Inari have reached a confidential settlement resolving a lawsuit

have reached a confidential settlement resolving a lawsuit filed by Corteva in September 2023 over access to and use of seed...

09-29-26

Chipotle Reaches 1,500 Chipotlanes as Drive-Thru Format Remains Central to Expansion Chipotle Mexican Grill has opened its 1,500th Chipotlane, marking

Chipotle Mexican Grill has opened its 1,500th Chipotlane, marking another milestone in the company’s North American growth strategy and the continued expansion of its...

09-29-26

Trane Technologies Expands AI Data Center Cooling Portfolio With Two NVIDIA DSX-Based Designs Trane Technologies has introduced two new 250-megawatt

Trane Technologies has introduced two new 250-megawatt thermal management reference designs for high-density AI factories, expanding its data center cooling portfolio around the NVIDIA...

09-29-26

Avio USA Breaks Ground on Virginia Solid Rocket Motor Facility to Expand U.S. Defense Capacity Avio USA has broken ground

Avio USA has broken ground on its first U.S. manufacturing facility, a roughly 900,000-square-foot solid rocket motor plant in Hurt, Virginia, aimed at expanding...

09-29-26

Applied Materials and KIOXIA Partner to Advance Next-Generation AI Memory Technology Applied Materials and KIOXIA have formed a new R&D

have formed a new R&D partnership at Applied’s EPIC Center in Silicon Valley to develop next-generation memory technologies for AI...

09-29-26

CrowdStrike Brings Falcon Platform to OpenAI Marketplace CrowdStrike has made its Falcon cybersecurity platform available through the OpenAI Marketplace, expanding

CrowdStrike has made its Falcon cybersecurity platform available through the OpenAI Marketplace, expanding its partnership with OpenAI and creating a new purchasing route for...

09-29-26

Caterpillar Agrees to Acquire Fabick Cat Dealership Caterpillar has entered into an agreement to acquire John Fabick Tractor Company, a

Caterpillar has entered into an agreement to acquire John Fabick Tractor Company, a long-standing Cat dealer serving parts of Missouri and Illinois, all of...

09-29-26

Microchip Expands Single Pair Ethernet Portfolio for Automotive and Industrial Edge Networks Microchip Technology has expanded its 10BASE-T1S portfolio with

Microchip Technology has expanded its 10BASE-T1S portfolio with new transceivers and integrated endpoint devices designed to simplify Ethernet connectivity at the network edge. The...

09-29-26

Johnson & Johnson Highlights Two-Year IMAAVY Data Showing Sustained Disease Control in gMG Johnson & Johnson reported new two-year data

Johnson & Johnson reported new two-year data for IMAAVY in generalized myasthenia gravis, showing sustained improvements in daily function and muscle strength among adolescents...

09-29-26

NYSE:JNJFollow

Track all markets on TradingView - Prices are not updated in real time

Johnson & Johnson Highlights Two-Year IMAAVY Data Showing Sustained Disease Control in gMG

Johnson & Johnson reported new two-year data for IMAAVY in generalized myasthenia gravis, showing sustained improvements in daily function and muscle strength among adolescents treated in the Phase 2/3 Vibrance-MG study.

At Week 108, patients with available data maintained a mean 2.88-point improvement in the MG-ADL score and an 8.25-point improvement in the QMG score from baseline. Corticosteroid use also declined, with three of six adolescents taking steroids at study entry reducing their dose and one discontinuing treatment after two years. No new safety signals were identified.

Johnson & Johnson also presented retrospective real-world data from healthcare professionals treating adults with anti-AChR or anti-MuSK antibody-positive gMG. Fluctuating symptom control was cited as the most common reason for stopping a previous advanced therapy.

Among 97 patients who switched to IMAAVY, 73.2% were reported as “much improved” or “very much improved.” Among patients receiving prednisone, 76.4% reduced their dose and 5.5% discontinued it.

IMAAVY is an FcRn blocker approved for adults and patients aged 12 and older with antibody-positive generalized myasthenia gravis. The new findings add longer-term evidence supporting sustained disease control and reduced corticosteroid dependence.

💬 🔗

WS Investor 09-29-26

Johnson & Johnson Highlights Two-Year IMAAVY Data Showing Sustained Disease Control in gMG

Johnson & Johnson reported new two-year data for IMAAVY in generalized myasthenia gravis, showing sustained improvements in daily function and muscle strength among adolescents treated in the Phase 2/3 Vibrance-MG long-term extension study.

At Week 108, patients with available data maintained a mean improvement of 2.88 points on the MG-ADL scale and 8.25 points on the QMG scale from baseline. Corticosteroid use also declined, with three of six adolescents on steroids at study entry reducing their dose and one discontinuing treatment after two years. No new safety signals were identified over the treatment period.

Johnson & Johnson also presented real-world survey data from healthcare professionals treating adults with anti-AChR or anti-MuSK antibody-positive gMG. Fluctuating symptom control was the most frequently cited reason for discontinuing a prior advanced therapy, while a consistent treatment schedule and expectations for improved efficacy were the main reasons for switching to IMAAVY.

Among 97 patients who transitioned to IMAAVY, healthcare professionals reported that 73.2% were “much improved” or “very much improved.” Among patients receiving prednisone, 76.4% reduced their dose and 5.5% discontinued it.

IMAAVY is an FcRn blocker approved for adults and patients aged 12 years and older with anti-AChR or anti-MuSK antibody-positive generalized myasthenia gravis. The latest data strengthen Johnson & Johnson’s clinical case for the treatment by showing durability of response and potential steroid-sparing benefits across longer-term use.

💬 🔗

WS Investor 09-29-26

Johnson & Johnson’s TREMFYA Meets Key Endpoints in Phase 4 Axial Psoriatic Arthritis Study

Johnson & Johnson (NYSE: JNJ) said TREMFYA (guselkumab) met the primary and major secondary endpoints in the Phase 4 STAR study evaluating biologic-naïve adults with active psoriatic arthritis and axial involvement. The company said the treatment improved spinal pain, stiffness and other axial symptoms while also reducing MRI-confirmed inflammation.

TREMFYA achieved a significant improvement in the BASDAI disease activity score at Week 24 versus placebo and also met secondary endpoints measuring axial symptoms through ASDAS-CRP and inflammation of the sacroiliac joints by MRI. Johnson & Johnson said the safety profile was consistent with TREMFYA’s established profile in psoriatic arthritis, with no new safety signals identified.

The STAR study enrolled 411 patients and is notable for using MRI-confirmed axial inflammation both for patient selection and for assessing treatment response. Johnson & Johnson said the results strengthen the evidence for TREMFYA in axial psoriatic arthritis, an area where dedicated prospective trials remain limited.

TREMFYA is already approved for active psoriatic arthritis and several other inflammatory diseases, and Johnson & Johnson recently received an FDA label expansion recognizing its ability to inhibit progression of structural joint damage in adults with active PsA. Detailed STAR efficacy and safety data are expected at an upcoming scientific congress.

💬 🔗

Global Finance News 09-25-26

Johnson & Johnson Highlights Strong Long-Term Survival Potential for TECVAYLI-DARZALEX Combination

Johnson & Johnson reported new MajesTEC-3 analyses suggesting that TECVAYLI plus DARZALEX FASPRO could materially improve long-term outcomes for patients with relapsed or refractory multiple myeloma treated as early as second line.

A model-based analysis estimated that about 87% of patients receiving the combination could eventually have a mortality risk similar to an age-matched general population. Projected remaining life expectancy was 18.5 years with TECVAYLI-DARZALEX versus 4.9 years with the standard-of-care comparator, approaching 21.1 years for the matched general population.

A separate analysis showed that the combination reduced the risk of disease progression by 90% versus standard care. At 36 months, progression had occurred in 8.7% of patients receiving TECVAYLI-DARZALEX compared with 62.1% in the control group. Overall survival at three years was 83.3% versus 65.0%, while non-relapse mortality was not significantly different between the groups.

The findings build on the Phase 3 MajesTEC-3 trial, which evaluates the combination in patients who had received one to three prior therapies. Johnson & Johnson said continued follow-up will be needed to determine whether the model-based long-term survival projections are borne out over time.

The data strengthen the case for moving TECVAYLI earlier in the multiple myeloma treatment pathway and reinforce Johnson & Johnson’s broader strategy of combining bispecific antibodies with established myeloma therapies.

💬 🔗

The Investor 09-23-26

Johnson & Johnson’s CAPLYTA Shows Rapid Improvement in Bipolar Mania in Phase 3 Study

Johnson & Johnson reported positive Phase 3 results for CAPLYTA in adults with manic episodes associated with bipolar I disorder, with the drug significantly reducing manic symptoms versus placebo and showing improvement as early as Day 3.

The pivotal Study 451 met its primary endpoint. CAPLYTA 42 mg produced a 4.8-point greater reduction in the Young Mania Rating Scale score versus placebo at Week 3, with an effect size of -0.69 and p<0.0001. Benefits were sustained through Week 3.

Clinical response was also stronger with CAPLYTA, with 45.8% of treated patients achieving at least a 50% reduction in mania symptoms versus 20.9% for placebo. Patients also showed significantly greater improvement in overall illness severity.

The safety profile was consistent with CAPLYTA’s established profile, with dry mouth and nausea the most common treatment-related adverse events reported at higher rates than placebo.

CAPLYTA is already approved for bipolar depression, schizophrenia and as adjunctive treatment for major depressive disorder, but it is not currently approved for manic episodes in bipolar I disorder. A second pivotal Phase 3 mania study has been completed and is under analysis.

💬 🔗

European Investor 09-21-26

Johnson & Johnson’s RYBREVANT Combination Extends Median Survival in Advanced Lung Cancer Study

Johnson & Johnson reported final Phase 3 data showing that RYBREVANT combined with chemotherapy achieved a median overall survival of 34.3 months in patients with advanced non-small cell lung cancer carrying EGFR exon 20 insertion mutations, compared with 27.9 months for chemotherapy alone.

The PAPILLON study evaluated first-line RYBREVANT plus carboplatin-pemetrexed against chemotherapy alone. Johnson & Johnson said the combination extended median survival by more than six months despite 76% of eligible patients in the chemotherapy group later crossing over to RYBREVANT after their disease progressed.

In the protocol-specified final analysis, the overall-survival hazard ratio was 0.87 and the result was not statistically significant. However, a prespecified analysis adjusting for crossover showed a 43% reduction in the risk of death, with a hazard ratio of 0.57 and nominal P value of 0.003. The treatment also extended progression-free survival through second disease progression to 28.3 months from 17.5 months.

The results are significant for a difficult-to-treat form of lung cancer. EGFR exon 20 insertion mutations account for roughly 12% of EGFR mutations and historically have been associated with median overall survival of about 16–24 months and a five-year survival rate of just 8%.

RYBREVANT is a bispecific antibody designed to target both EGFR and MET, pathways involved in tumor growth and treatment resistance. The latest results strengthen Johnson & Johnson’s clinical evidence for the therapy in EGFR-mutated lung cancer.

💬 🔗

WS Investor 09-14-26

Johnson & Johnson Receives CE Mark for New ACUVUE OASYS MAX Reusable Contact Lenses

Johnson & Johnson has received CE Marking for ACUVUE OASYS MAX 2-Week, expanding its ACUVUE portfolio with a new reusable contact lens designed to provide comfort and visual clarity throughout a two-week wear cycle. The product is expected to launch in select European markets later this year, followed by a broader rollout in 2027 and 2028.

The new lens incorporates the company’s OptiBlue Light Filter, which filters at least 60% of blue-violet light, along with TearStable Technology designed to retain moisture and Class 1 UV blocking. Johnson & Johnson is positioning the product for consumers facing increased screen exposure and demanding visual environments.

The company said 99% of existing ACUVUE OASYS 2-Week users participating in clinical testing were successfully refitted into the new lens using the same power, base curve and diameter.

The CE Mark clears ACUVUE OASYS MAX 2-Week for European markets. The product has not been approved by the U.S. Food and Drug Administration and is currently unavailable for sale in the United States.

💬 🔗

The Investor 09-10-26

Johnson & Johnson to Present Phase 3 CAPLYTA Data at 2026 Psych Congress

Johnson & Johnson (NYSE: JNJ) will present 24 abstracts spanning its neuropsychiatry portfolio at the 2026 Psych Congress Annual Meeting, scheduled for September 15-19 in New Orleans.

A key focus will be the first presentation of pivotal Phase 3 data evaluating CAPLYTA (lumateperone) for the acute treatment of manic episodes, including episodes with mixed features, associated with bipolar I disorder. Additional CAPLYTA research will cover bipolar depression and major depressive disorder, including depressive symptoms, remission, patient subgroups and metabolic outcomes.

The company will also present new analyses of SPRAVATO (esketamine) examining its impact on anhedonia, a core symptom of depression associated with poorer treatment outcomes.

Johnson & Johnson’s broader neuroscience pipeline will also be represented. Phase 3 clinical trial data for seltorexant in major depressive disorder with insomnia symptoms are scheduled for presentation, alongside real-world research examining the disease burden and management of these patients.

Additional studies will focus on long-acting injectable treatments for schizophrenia, including hospitalization, relapse risk and patient treatment satisfaction.

The upcoming presentations highlight Johnson & Johnson’s efforts to expand its presence across mood disorders and other high-burden neuropsychiatric conditions, with the pivotal CAPLYTA bipolar mania results representing one of the most closely watched updates.

💬 🔗

The Investor 09-08-26

Johnson & Johnson Wins FDA Approval for IMAAVY in First-Ever wAIHA Treatment

Johnson & Johnson (NYSE: JNJ) received a major regulatory win after the U.S. Food and Drug Administration approved IMAAVY (nipocalimab-aahu) for warm autoimmune hemolytic anemia, or wAIHA, in adults and patients aged 12 and older who are currently or were previously treated with corticosteroids. It is the first FDA-approved therapy specifically for the rare and potentially life-threatening disease.

Why the FDA Approval Matters

Warm autoimmune hemolytic anemia occurs when pathogenic IgG autoantibodies attack and destroy red blood cells, potentially causing severe anemia and debilitating fatigue. Previous treatment options were largely corticosteroids and immunosuppressants, which broadly suppress the immune system rather than specifically targeting the disease-driving antibodies.

IMAAVY takes a more targeted approach. The drug blocks the neonatal Fc receptor, or FcRn, reducing circulating pathogenic IgG antibodies while preserving B-cell function.

The approval was supported by the Phase 2/3 ENERGY study. Approximately three times as many patients receiving the approved IMAAVY dose achieved a durable hemoglobin response compared with placebo at 24 weeks. Patients also showed a mean hemoglobin increase of 1 g/dL as early as Week 1, while fatigue scores improved versus placebo.

IMAAVY Franchise Expands

The approval also broadens the commercial potential of IMAAVY. The drug was previously approved in the U.S. for generalized myasthenia gravis, making wAIHA its second approved indication. Johnson & Johnson is studying nipocalimab across several additional autoantibody-driven diseases.

For Johnson & Johnson, the FDA decision strengthens its immunology portfolio while giving IMAAVY a first-mover position in a disease with significant unmet medical need.

💬 🔗

WS Investor 08-25-26

Johnson & Johnson (NYSE: JNJ) gained 3.5% on Friday after receiving fresh analyst support, helping extend the stock's recent strength.

Johnson Rice initiated coverage with a $270 price target, while Guggenheim raised its price target to $270 from $266 and maintained its Buy rating. The updated analyst views reflect confidence in the company's diversified healthcare business, resilient pharmaceutical portfolio, and improving growth outlook.

Analysts continue to view Johnson & Johnson as well positioned to benefit from steady demand for its innovative medicines, expanding medtech business, and strong cash generation. The company is also expected to maintain its defensive appeal amid ongoing macroeconomic uncertainty.

The positive analyst actions reinforced investor sentiment, supporting gains in Johnson & Johnson shares as healthcare stocks attracted renewed interest.

💬 🔗

Global Finance News 06-26-26

Load More

05-02-26WS News

12-30-25European Investor

10-14-25European Investor

10-04-25European Investor

04-15-25WS News

NYSE:CATFollow

Track all markets on TradingView - Prices are not updated in real time

Caterpillar Agrees to Acquire Fabick Cat Dealership

Caterpillar has entered into an agreement to acquire John Fabick Tractor Company, a long-standing Cat dealer serving parts of Missouri and Illinois, all of Wisconsin and Michigan’s Upper Peninsula.

Fabick Cat operates 37 locations across its territory and has represented the Caterpillar brand for more than a century. Caterpillar said the transaction is intended to support a smooth ownership transition while preserving the local service and customer relationships built by the dealership.

The acquisition would bring Fabick’s dealership operations directly under Caterpillar ownership, giving the company greater control over sales, service and customer support across a sizable Midwestern territory.

Caterpillar said it plans to work with the existing Fabick team and build on the dealership’s established customer base. Fabick management also said the transaction should strengthen its ability to provide customers with services, technology and technical expertise.

The deal remains subject to regulatory approval and other customary closing conditions. Caterpillar expects the transaction to close within 30 days.

The acquisition represents a notable move by Caterpillar into direct ownership of a major dealer operation, while maintaining the broader structure of its global dealer network.

💬 🔗

WS Investor 09-29-26

Caterpillar Expands Autonomous Hauling After 3.5 Million-Ton Quarry Pilot

Caterpillar (NYSE: CAT) and Luck Stone are expanding autonomous hauling technology to two additional Virginia quarries following an 18-month pilot at the Bull Run Quarry. Autonomous trucks at the site have hauled more than 3.5 million tons since operations began in November 2024.

The expansion will deploy Caterpillar’s autonomous technology across fleets of Cat 775 haul trucks at Luck Stone’s Boscobel and Bealeton operations. It will mark the first deployment of Caterpillar’s autonomous haulage system on the Cat 775, an important truck model for the quarry industry.

Luck Stone said autonomous operations have improved production consistency and workplace safety while creating opportunities for employees to move into more technology-focused roles. The companies are now using experience from the Bull Run deployment to scale the technology across additional sites.

Caterpillar said its autonomous trucks globally have now hauled more than 13 billion tonnes and traveled over 455 million kilometers with no reported injuries while operating, highlighting the growing commercial adoption of autonomous heavy equipment.

💬 🔗

The Investor 09-15-26

Caterpillar Partners With FieldAI to Advance AI-Powered Robotics and Industrial Automation

Caterpillar (NYSE: CAT) is collaborating with FieldAI to develop physical AI, autonomous robotics and digital-twin technologies for construction sites, factories and other complex industrial environments, expanding the heavy-equipment giant’s push into AI-powered operations.

The collaboration combines Caterpillar’s industrial expertise, engineering capabilities and operational data with FieldAI’s robot foundation models. The goal is to enable autonomous systems to operate in dynamic industrial environments where conventional automation can struggle, improving worker safety, productivity and operational efficiency.

Initial applications include autonomous inspections, real-time digital twins of jobsites and manufacturing facilities, AI-powered situational awareness and operational optimization. These systems can analyze equipment and infrastructure conditions, identify potential risks and use simulation and automation to improve workflows.

NVIDIA technology will play an important role in the initiative. Caterpillar and FieldAI plan to use NVIDIA accelerated computing and NVIDIA Omniverse technologies alongside high-fidelity digital twins built from real-world operational data. The combination is intended to improve site visibility and accelerate decision-making while supporting increasingly autonomous industrial operations.

FieldAI’s technology is robot-agnostic, allowing its autonomy software and foundation models to operate across different robotic platforms rather than being tied to a single machine. Caterpillar selected the company partly because of its experience deploying autonomous technology in complex and unpredictable industrial environments.

For Caterpillar, the partnership extends AI beyond software analytics and into physical machines and industrial workflows. As construction, mining and manufacturing customers face labor shortages and pressure to improve productivity, AI-enabled autonomy could become an increasingly important differentiator across Caterpillar’s equipment and technology ecosystem.

💬 🔗

The Investor 09-02-26

Caterpillar Stock Rises 5.7% After Cat Financial Reports Strong Q2 Results

Caterpillar (NYSE: CAT) shares gained 5.7% on Tuesday after its financing subsidiary, Cat Financial, reported solid second-quarter results, highlighting continued strength in equipment financing demand, portfolio quality and lending activity.

Cat Financial reported second-quarter revenue of $991 million, up 10% year over year, while profit increased 6% to $145 million. Profit before taxes rose 13% to $206 million, supported by higher average earning assets, although partially offset by a higher provision for credit losses.

Financing Business Shows Continued Strength

Retail new business volume increased 9% year over year to $3.92 billion, reflecting higher financing activity across all customer segments.

The growth in lending suggests continued demand for Caterpillar equipment despite a mixed macroeconomic environment and supports the company's broader equipment sales ecosystem.

Management said the financing business remains focused on providing financial solutions that help Caterpillar customers and dealers invest in new equipment while maintaining disciplined portfolio management.

Credit Quality Remains Healthy

Cat Financial continued to report strong credit performance during the quarter.

Past-due accounts improved to 1.31% from 1.62% a year earlier, while the allowance for credit losses remained stable at 0.84% of finance receivables. Net write-offs increased only modestly to $20 million from $18 million a year ago, indicating that overall portfolio quality remains resilient.

What to Watch

The strong share price reaction suggests investors welcomed the healthy financing trends and stable credit performance, which are often viewed as indicators of underlying demand for Caterpillar equipment. Going forward, investors will monitor global construction and mining activity, equipment demand, financing volumes and credit quality for further signs of strength across Caterpillar's business.

💬 🔗

European Investor 08-04-26

Caterpillar Stock Falls 6.5% as Baird Downgrades Rating Despite High Price Target

Caterpillar (NYSE: CAT) shares fell 6.5% on Wednesday after Robert W. Baird downgraded the construction and mining equipment maker to **Neutral** from **Outperform**, while lowering its price target to **$900 from $1,200**.

Although the new $900 target remains above the stock's current trading price of around $786, the downgrade suggests Baird believes Caterpillar's near-term upside has become more limited after its recent performance and amid a more balanced risk-reward profile.

The revised target still implies meaningful upside, but the sharp reduction from the previous $1,200 estimate reflects a more cautious outlook for the company's earnings trajectory and valuation. Investors often react more strongly to rating downgrades than to the absolute price target, particularly for widely followed industrial companies.

The downgrade comes as Caterpillar faces uncertainty surrounding global construction activity, mining capital spending, and infrastructure demand. Investors are also monitoring the impact of slowing economic growth in some regions and the pace of equipment replacement spending by customers.

Despite Wednesday's decline, Caterpillar continues to benefit from a strong competitive position, healthy cash generation, and long-term demand supported by infrastructure investment, energy, and mining projects. However, Baird's more cautious stance indicates that much of these positives may already be reflected in the stock, leading the firm to adopt a more neutral view on future performance.

💬 🔗

The Investor 07-29-26

Caterpillar Drops Despite Baird Price Target Increase

Caterpillar (NYSE: CAT) shares fell 5.6% on Friday despite Robert W. Baird raising its price target on the construction and mining equipment manufacturer to *$1,200 from $1,165*, while maintaining an *Outperform* rating.

Baird's higher price target reflects continued confidence in Caterpillar's long-term earnings power, supported by resilient demand for heavy equipment, infrastructure spending, and the company's disciplined capital allocation. The reaffirmed Outperform rating indicates the firm expects Caterpillar to continue outperforming its peers over time.

Despite the bullish analyst update, Caterpillar came under broad selling pressure during Friday's session. However, the increased price target suggests Wall Street remains optimistic that the recent pullback does not alter the company's strong long-term fundamentals and growth outlook.

💬 🔗

The Investor 06-27-26

Caterpillar Shares Rise After JPMorgan Raises Price Target to $1,165

Caterpillar (NYSE: CAT) gained 1.3% as investors reacted to a bullish analyst update from JPMorgan. Analyst Tami Zakaria raised her price target on the construction and mining equipment giant to $1,165 from $1,125 while maintaining an Overweight rating.

The higher target reflects growing confidence in Caterpillar's ability to benefit from strong long-term demand across infrastructure, mining, energy, and industrial markets. The company remains one of the most closely watched indicators of global economic activity due to its broad exposure to construction and resource development projects worldwide.

Investor sentiment toward Caterpillar has also been supported by expectations that lower energy prices and easing geopolitical tensions could help improve the outlook for global growth. The recent U.S.-Iran agreement has reduced concerns about potential disruptions to energy markets, while declining oil prices have eased inflation pressures and improved expectations for future interest-rate cuts.

Caterpillar is particularly well-positioned to benefit from continued investment in infrastructure and natural resources. Mining customers continue to invest in equipment to support demand for critical minerals used in artificial intelligence infrastructure, electric vehicles, and renewable energy technologies. At the same time, government-backed infrastructure projects remain a significant source of demand for construction machinery.

The company has also demonstrated strong pricing discipline and operational execution in recent years, helping support margins despite fluctuations in end-market demand. Investors have increasingly focused on Caterpillar's ability to generate cash flow and return capital to shareholders through dividends and share repurchases.

JPMorgan's target increase adds to the constructive outlook surrounding industrial and capital equipment companies, which have benefited from resilient economic conditions and expectations for continued spending on infrastructure and industrial modernization.

The stock's advance suggests investors welcomed the analyst's more optimistic assessment and continue to view Caterpillar as a key beneficiary of long-term industrial investment trends and improving macroeconomic conditions.

💬 🔗

WS Investor 06-18-26

Caterpillar Surges 9% as AI Infrastructure Boom and Record Backlog Power Blowout Quarter

Caterpillar shares are up 9% in trading today, as a Q1 2026 earnings report that blew past expectations on every key metric underscored how the AI infrastructure buildout is becoming a powerful new growth engine for the industrial giant.

Revenue rose 22% year-over-year to $17.42 billion, well above the $16.21 billion consensus, while adjusted EPS came in at $5.54, beating the $4.64 estimate by a wide 19% margin. The beat was broad-based: construction segment revenue jumped 38% while the power and energy segment rose 22%, with power equipment benefiting directly from the AI data center infrastructure boom and higher dealer sales lifting construction. (GuruFocus, CNBC)

Sales growth was driven by higher volume of $2.3 billion and favorable price realization of $426 million. On the financing side, Cat Financial delivered solid supporting numbers, with retail new business volume up 8% to $3.19 billion and past dues falling to a historically low 1.39%. (Stock Titan)

Caterpillar raised its annual revenue forecast following the beat, with a record backlog providing management with confidence in continued momentum through the rest of 2026. The company also deployed $5.7 billion in share repurchases and dividends during the quarter alone. (GuruFocus)

💬 🔗

WS Investor 04-30-26

Caterpillar Inc. to Announce First-Quarter 2026 Financial Results on April 30

💬 🔗

Global Finance News 04-17-26

The Board of Directors of Caterpillar Inc. (NYSE: CAT) decided the quarterly dividend of $1.51 per share of common stock payable May 19, 2026, to shareholders of record at the close of business April 20, 2026.

💬 🔗

WS Investor 04-08-26

Load More

09-29-26WS News

08-14-26WS Investor

07-02-26Global Finance News

06-30-26WS News

SwitzerlandFollow

Track all markets on TradingView - Prices are not updated in real time

Swiss KOF Leading Indicator Jumps to 109.1 in September

Switzerland’s KOF Leading Indicator rose to 109.1 in September from 107.5 previously, well above the 106.0 market forecast.

The stronger-than-expected reading suggests the Swiss economy may be entering the coming months with firmer underlying momentum. Because the KOF index is designed to anticipate changes in economic activity, the increase points to improving conditions across forward-looking components of the economy.

💬 🔗

WS News 09-29-26

Swiss National Bank Holds Policy Rate at 0.00%

The Swiss National Bank kept its policy rate unchanged at 0.00% in its third-quarter decision, matching market expectations and leaving rates steady from the previous meeting.

💬 🔗

WS News 09-24-26

Swiss Producer Prices Jump 0.7% in August, Well Above Forecast

Switzerland’s producer price index rose 0.7% month over month in August, significantly exceeding market expectations for a 0.1% increase.

The reading also marked a sharp reversal from the previous month’s 0.1% decline, signaling a notable pickup in price pressures at the producer level.

💬 🔗

WS News 09-14-26

Swiss Consumer Confidence Remains Weak as SECO Index Holds at -33

Consumer sentiment in Switzerland remained unchanged, with the SECO Consumer Climate index coming in at -33, matching both the forecast and the previous reading.

The persistently negative figure indicates Swiss households remain cautious about economic conditions and their financial outlook.

💬 🔗

European Investor 09-11-26

Swiss Inflation and GDP Beat Forecasts, Strengthening the Economic Outlook

Switzerland delivered a pair of stronger-than-expected economic readings, with consumer prices rising sharply in August while second-quarter economic growth exceeded forecasts.

Swiss CPI increased 0.4% month over month in August, significantly above expectations for no change and reversing the 0.1% decline recorded in the previous month. The upside inflation surprise suggests price pressures strengthened during the month and could reduce the scope for the Swiss National Bank to pursue easier monetary policy.

Economic growth also surprised to the upside. Switzerland’s GDP expanded 1.9% quarter over quarter in the second quarter, beating the 1.5% consensus and accelerating sharply from the previous quarter’s 0.6% growth. On an annual basis, GDP increased 2.8%, compared with 0.5% previously.

💬 🔗

WS News 09-03-26

Swiss KOF Leading Indicator Jumps to 106.7 in August

Switzerland’s KOF Leading Indicator climbed to 106.7 in August, significantly above the 103.0 market forecast and up from 104.2 previously.

The stronger-than-expected reading signals improving momentum in the Swiss economy and suggests economic activity could remain relatively resilient in the months ahead.

💬 🔗

The Investor 08-28-26

Swiss Employment Rises to 5.70 Million in Q2

Employment in Switzerland increased in the second quarter of 2026, pointing to continued resilience in the Swiss labor market.

The number of employed people rose to 5.698 million, up from 5.537 million in the previous period. That represents an increase of roughly 161,000 workers, or about 2.9%.

💬 🔗

European Investor 08-27-26

Switzerland GDP Growth Accelerates to 1.5% in Q2

Switzerland’s economy expanded 1.5% quarter over quarter in the second quarter of 2026, accelerating sharply from the 0.7% growth recorded in the previous period, according to the data provided.

The stronger reading points to a significant acceleration in Swiss economic activity during the quarter and suggests that growth momentum remained resilient despite uncertainty surrounding global trade and external demand.

💬 🔗

WS Investor 08-14-26

Swiss Consumer Sentiment Improves in Third Quarter

Consumer confidence in Switzerland rebounded moderately in the third quarter, signaling a slight easing in household pessimism as broader economic expectations stabilized.

Swiss Consumer Climate Index rose to -33 points in Q3. The figure came in slightly above market forecasts of -34 points and marked a notable recovery from the -40 points recorded in the second quarter.

💬 🔗

WS Investor 08-07-26

Switzerland Producer Prices Fall Less Than Expected in June

Switzerland's producer prices declined in June, although the monthly decrease was smaller than economists had expected, suggesting producer-level deflationary pressures eased slightly.

The Producer Price Index (PPI) fell 0.3% month over month in June, outperforming market expectations for a 0.5% decline. The reading followed a 0.4% decrease recorded in May.

💬 🔗

Global Finance News 07-14-26

Load More

11-11-25The Investor

08-04-25The Investor

03-20-25The Investor

NASDAQ:DXCMFollow

Dexcom Report Highlights Large Untapped CGM Opportunity in Type 2 Diabetes

Dexcom released its 2026 State of Type 2 Report at the EASD meeting, highlighting what the company sees as a significant gap between the clinical value of continuous glucose monitoring and its current adoption among people with Type 2 diabetes.

The report surveyed more than 800 healthcare professionals and 2,500 people with Type 2 diabetes across eight countries. Dexcom identified three main barriers to broader CGM use: health literacy, technology literacy and access.

Healthcare professionals expressed strong support for CGM. According to the survey, 89% said CGM helps them assess treatment adherence between appointments. Among current users, more than half said they followed their treatment plan more closely after adopting CGM.

Access remains a major constraint. About 55% of people with Type 2 diabetes reported limited knowledge of CGM, while reimbursement and coverage challenges were cited by 90% of U.S. healthcare professionals and 53% of those in the other surveyed countries.

The report also pointed to a growing link between GLP-1 therapies and CGM use. Among Type 2 patients using GLP-1 drugs, 58% also used CGM, compared with just 27% of non-insulin users overall. Dexcom said this suggests further room for adoption as GLP-1 use expands.

Separately, Dexcom announced a partnership with Team Novo Nordisk to become the professional cycling team’s official continuous glucose monitoring partner, supporting research, education and awareness in Type 1 diabetes.

💬 🔗

WS Investor 09-29-26

DexCom, Inc. (NASDAQ:DXCM) plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026.

💬 🔗

Global Finance News 04-03-26

DexCom announced new clinical data at the Advanced Technologies and Treatments for Diabetes (ATTD) 2026 conference showing that long-term use of its Dexcom G7 continuous glucose monitoring (CGM) system can improve A1C levels and support weight management in people with Type 2 diabetes who are not using insulin.

The company also presented evidence linking Dexcom CGM use with reduced hospitalizations and emergency visits related to diabetic ketoacidosis in patients with Type 1 diabetes.

Dexcom said the findings reinforce the potential for CGM technology to become a broader standard of care across diabetes populations, while the company also outlined upcoming product features and its future product roadmap during the conference.

Business Wire

💬 🔗

The Investor 03-11-26

DexCom reported strong fourth quarter and full-year 2025 results, driven by double-digit revenue growth and margin expansion.

In Q4 2025, revenue rose 13% year over year to $1.26 billion (12% organic). U.S. revenue increased 11%, while international revenue grew 18%. GAAP operating income reached $323.0 million (25.6% margin), up 860 basis points from the prior year. GAAP net income was $267.3 million, or $0.68 per diluted share.

For full-year 2025, revenue grew 16% to $4.66 billion (15% organic). GAAP operating income totaled $911.8 million (19.6% margin), and non-GAAP operating income reached $969.3 million (20.8% margin).

Strategically, Dexcom launched the G7 15 Day CGM system in the U.S., received FDA clearance for Smart Basal, and expanded CGM coverage in Québec.

For 2026, Dexcom reaffirmed guidance of $5.16–$5.25 billion in revenue (11–13% growth), non-GAAP operating margin of 22–23%, and adjusted EBITDA margin of 30–31%. The company ended the year with $2.0 billion in cash and no borrowings under its credit facility.

Business Wire

💬 🔗

WS Investor 02-13-26

Dexcom announced it will roll out advanced AI-enabled enhancements to its Stelo app in the coming weeks, strengthening how users track meals and understand daily glucose patterns. The updated Smart Food Logging feature now integrates a comprehensive nutrition database with over one million food options, providing detailed breakdowns of calories, carbohydrates, protein, fats, fiber and other nutrients. Meals can be logged via text search, barcode scanning or photos, reducing friction in daily tracking and helping users better understand how specific foods and macronutrients affect glucose levels.

In addition, Stelo will introduce a redesigned Daily Insights experience with a personalized, card-based interface. Users will receive tailored recommendations based on prior-day glucose data, nutrition, activity and sleep, alongside AI-driven behavioral insights designed to support reflection and healthier decision-making over time. Dexcom said these features are part of its broader effort to transform personal glucose management and support long-term metabolic health, ahead of a fully reimagined Stelo app experience planned for later in 2026.

💬 🔗

European Investor 02-05-26

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

💬 🔗

WS Investor 01-27-26

DexCom, Inc. reported preliminary, unaudited results for the fourth quarter and full year 2025, delivering solid revenue growth and providing an initial outlook for 2026. Fourth-quarter revenue reached approximately $1.26 billion, up 13% year over year, supported by U.S. revenue of about $892 million and international revenue of roughly $368 million.

For full-year 2025, Dexcom said revenue totaled approximately $4.66 billion, representing 16% growth compared with 2024, while reiterating its non-GAAP gross margin guidance of around 61% and operating margin guidance of 20–21%. Chief Executive Officer Jake Leach said the company closed 2025 above the high end of its guidance, highlighting the initial launch of the G7 15 Day sensor and continued momentum in the continuous glucose monitoring market.

Looking ahead, Dexcom expects 2026 revenue of $5.16 billion to $5.25 billion, implying growth of about 11–13%, driven by increasing CGM adoption, international expansion, and new product initiatives. The company also forecasts non-GAAP gross margins of 63–64% and operating margins of 22–23% in 2026, and plans to release its audited fourth-quarter and full-year 2025 results on February 12, 2026.

Source: Business Wire

💬 🔗

The Investor 01-12-26

Dexcom to launch G7 15 Day continuous glucose monitoring system in the U.S. on December 1

DexCom announced that its new Dexcom G7 15 Day CGM system will launch in the United States on December 1, offering real-time glucose tracking for an extended 15.5-day wear period. The system will initially be available through durable medical equipment providers and will be covered for Medicare beneficiaries, meeting CMS requirements for therapeutic CGM devices.

The updated sensor provides longer wear, reduced waste, and maintains Dexcom’s accuracy with an overall MARD of 8.0%. Users keep all G7 features, including Apple Watch direct-to-watch connectivity, automated activity and meal logging, Clarity data integration, and remote sharing with caregivers. At launch, the 15 Day model will integrate with iLet Bionic Pancreas and Omnipod 5, with Tandem compatibility expected soon.

Dexcom said the extended-wear version responds to user demand for fewer sensor changes while preserving reliability and performance.

💬 🔗

WS Investor 11-20-25

Dexcom Smart Basal cleared by FDA as first CGM-integrated basal insulin dosing optimizer

Dexcom announced FDA clearance for Dexcom Smart Basal, making it the first and only CGM-integrated basal insulin dosing optimizer for adults with Type 2 diabetes using glargine U-100 long-acting insulin. The system uses Dexcom G7 15-Day sensor data plus logged insulin doses to generate personalized daily dose recommendations, aiming to simplify and accelerate basal insulin initiation. The tool continuously analyzes all CGM readings rather than relying on a single fasting measurement and automatically adjusts recommendations when low-glucose events occur. Smart Basal will be incorporated into the Dexcom G7 15-Day app shortly after its U.S. launch, with international expansion planned.

💬 🔗

Global Finance News 11-19-25

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2025 financial results after market close on Thursday, October 30, 2025. Management will hold a conference call to review the company's third quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day.

💬 🔗

WS Investor 10-02-25

Load More

NYSE:JEFFollow

Track all markets on TradingView - Prices are not updated in real time

Jefferies Stock Falls 1% Despite Record Investment Banking and Equities Revenue

Jefferies Financial Group shares fell 1% after the company reported fiscal third-quarter results that included record quarterly revenue in both Investment Banking and Equities.

Total net revenue rose to $2.22 billion from $2.05 billion a year earlier, while net earnings attributable to common shareholders increased to $260.6 million from $224.0 million. Diluted EPS improved to $1.08 from $1.01.

Investment Banking was a major bright spot, with revenue up 17% year over year to $1.33 billion. Advisory revenue reached a quarterly record and increased 25%, while Equity Underwriting jumped 69%. Capital Markets revenue rose 11% to $802 million, helped by record Equities revenue of $626 million, up 29%.

The weaker areas were Fixed Income and Asset Management. Fixed Income revenue fell 26% to $176 million as trading activity remained subdued, while asset management fees and investment return revenue declined to $34 million from $84 million because of weaker performance across several fund strategies.

Jefferies also continued returning capital to shareholders, repurchasing $70 million of stock during the quarter and restoring its future buyback authorization to $250 million. The board maintained a quarterly dividend of $0.40 per share.

The 1% decline suggests investors focused on the softer Fixed Income and Asset Management performance, as well as limited improvement in return on tangible equity, despite strong momentum in investment banking and equities.

💬 🔗

WS Investor 09-29-26

Jefferies Stock Falls 2.7% as BMO and UBS Cut Price Targets

Jefferies Financial Group shares fell 2.7% to $52.49 on Friday as BMO Capital Markets and UBS lowered their price targets on the investment banking and capital markets firm.

BMO Capital Markets analyst Brennan Hawken reduced the firm’s price target to $57 from $60 while maintaining a Market Perform rating. The new target represents roughly 9% upside from Jefferies’ current share price.

UBS analyst Michael Brown also lowered his target, cutting it to $61 from $65 while maintaining a Neutral rating. The revised UBS target implies approximately 16% upside.

Capital One separately set a $57 price target on Jefferies. The combination of lower targets from BMO and UBS reinforces a cautious analyst outlook and comes as Jefferies shares trade under pressure.

💬 🔗

Global Finance News 09-11-26

Jefferies Financial Group Inc. announced the pricing of a $1.5 billion public offering of 5.500% senior notes due 2036, as part of its funding activities. The notes will carry an effective yield of 5.605% and are scheduled to mature on February 15, 2036, with settlement expected on January 16, 2026, subject to customary closing conditions.

💬 🔗

WS Investor 01-14-26

Jefferies Financial Group announced it will acquire a 50% interest in Hildene Holding Company, expanding a strategic partnership formed in 2022. Jefferies will exchange its existing revenue share, part of its stake in a Hildene-managed private fund, and $340 million in cash for half of the firm. Hildene’s principals will contribute their ownership and approximately $250 million of fund-related equity to retain the remaining 50%. The transaction is expected to close in Q3 2026, pending regulatory and client approvals.

The move coincides with Hildene’s agreement to acquire SILAC, an annuity provider, for $550 million. SILAC manages about $10 billion in admitted assets and originated $2.5 billion in annuities in 2024. After closing, Hildene will also hold a majority stake in its affiliated reinsurer, Hildene Re. Jefferies expects the investment to be immediately accretive, funded largely by reducing other Leucadia Asset Management exposures, and to generate a $75 million pretax gain upon revaluing its pre-existing interest.

Executives from both firms said the expanded partnership strengthens their long-term credit investment strategies and positions Hildene to scale its platform and broaden origination capabilities.

💬 🔗

WS Investor 12-08-25

Jefferies downplays First Brands impact; details limited exposure, strong liquidity

Jefferies (NYSE: JEF) published a letter from CEO Rich Handler and President Brian Friedman addressing concerns tied to First Brands’ bankruptcy, saying any losses are “readily absorbable.” The firm cited $10.5B total equity, $8.5B tangible equity, and $11.5B cash (as of Aug. 31, 2025), plus momentum reflected in annualized Q3 results of ~$8.2B net revenue and ~$1.0B net earnings.

Jefferies detailed exposure primarily through Point Bonita Capital: $43M (5.9%) of receivables purchased from First Brands and about $2M indirect exposure via CLOs holding First Brands loans. Management said Point Bonita investors have submitted redemptions effective Dec. 31, 2025, to be paid pro rata over four quarters through Oct. 2026. The firm denied undisclosed fees, said it had no prior knowledge of fraud, and noted fees from Point Bonita equate to ~0.8% of Jefferies’ LTM net revenue.

Jefferies also pointed to its expanded SMBC alliance—including $2.5B in new credit facilities and SMBC’s plan to lift its stake to up to 20%—as further support for liquidity and business momentum.

💬 🔗

European Investor 10-14-25

Jefferies said that its exposure to the bankruptcy of First Brands Group is limited. Through Point Bonita Capital under Leucadia Asset Management, Jefferies holds a small stake in a $3 billion trade-finance portfolio that includes about $715 million of receivables linked to First Brands, whose remittances stopped in mid-September amid investigations into possible double factoring. Jefferies also disclosed that its Apex Credit Partners unit manages CLOs holding roughly $48 million of First Brands term loans, about 1 percent of its CLO assets, and confirmed it owns no other First Brands securities.

💬 🔗

WS Investor 10-08-25

Jefferies reported strong third-quarter 2025 results, with net earnings attributable to common shareholders rising to $224 million from $167 million a year earlier. Diluted EPS from continuing operations was $1.01, up from $0.72 in Q3 2024. Total net revenues climbed to $2.05 billion from $1.68 billion, driven by record investment banking advisory results, robust equities performance, and improved asset management revenues.

Return on adjusted tangible shareholders’ equity improved to 13.6% from 10.3% a year ago. Book value per share increased to $50.60, while adjusted tangible book value per fully diluted share rose to $33.38.

The Board declared a quarterly cash dividend of $0.40 per share, payable November 26, 2025. Management noted that a rebound in global market sentiment, coupled with Jefferies’ expanded talent base, global reach, and product offerings, has strengthened the firm’s position for long-term growth.

💬 🔗

The Investor 09-29-25

Load More

BrazilFollow

Track all markets on TradingView - Prices are not updated in real time

Brazil Unemployment Rate Holds at 5.3% in August

Brazil’s unemployment rate remained at 5.3% in August, matching both market expectations and the previous reading.

The unchanged figure suggests the labor market remained relatively tight, with no clear deterioration in employment conditions during the month.

💬 🔗

WS Investor 09-29-26

Brazil Foreign Direct Investment Reaches $7.4 Billion in August

Brazil recorded $7.40 billion in foreign direct investment in August, above the $6.90 billion market forecast.

The figure was only slightly below the previous month’s $7.46 billion, suggesting foreign investment inflows remained relatively strong despite broader global financial-market volatility

💬 🔗

WS News 09-28-26

Brazil Cuts Interest Rate to 13.75%, Matching Expectations

Brazil’s central bank cut its benchmark interest rate by 25 basis points to 13.75% on September 17, continuing the gradual easing of monetary policy.

The decision was in line with market expectations. The Selic rate had previously stood at 14.00%, meaning the latest move represents another step down from the considerably higher interest-rate levels seen earlier in the cycle.

💬 🔗

WS News 09-17-26

Brazil Retail Sales Fall 0.8% in July, Missing Forecasts

Brazilian retail sales weakened more than expected in July, adding to signs of softer consumer demand in Latin America’s largest economy.

Retail sales fell 0.8% month over month, compared with expectations for a 0.2% decline and following a 0.3% increase previously. On an annual basis, sales rose just 1.2%, well below the 2.2% forecast and slowing from 2.8%

💬 🔗

The Investor 09-15-26

Brazil Inflation Slows to 4.22% in August, Below Expectations

Brazil’s annual inflation rate eased more than expected in August, providing a positive signal for the country’s inflation outlook.

Consumer prices increased 4.22% year-over-year, below the 4.27% market forecast and slowing from 4.44% previously. The decline indicates that inflationary pressures continued to moderate during the month.

💬 🔗

WS Investor 09-11-26

Consumer Confidence Weakens in Argentina and Brazil in September

Consumer sentiment deteriorated in both Argentina and Brazil in September, according to the latest Thomson Reuters/Ipsos Primary Consumer Sentiment Index readings.

Argentina’s PCSI declined to 37.85 from 38.97 in August, leaving consumer confidence at a particularly weak level.

Brazil’s PCSI fell to 52.17 from 53.38, a decline of 1.21 points. Despite the monthly drop, Brazil remained above the 50-point level, indicating comparatively stronger consumer sentiment than Argentina.

The September readings point to softer consumer confidence across both of South America’s largest economies, although the gap remains substantial: Brazil’s index stands more than 14 points above Argentina’s.

💬 🔗

WS Investor 09-09-26

Brazil GDP Beats Forecasts in Q2 but Growth Slows From Strong First Quarter

Brazil’s economy expanded more than expected in the second quarter, although growth slowed substantially from the beginning of the year as high interest rates continued to restrain domestic activity.

GDP grew 0.5% quarter over quarter in Q2, beating expectations for a 0.4% increase but slowing from 1.1% growth in the first quarter. On an annual basis, the economy expanded 2.0%, also above the 1.8% forecast.

Agriculture was the strongest contributor, expanding 2.8% from the previous quarter, supported by strong soybean and coffee harvests. Services grew just 0.2%, while industrial activity edged up 0.1%.

💬 🔗

WS Investor 09-01-26

Brazil’s Gross Debt-to-GDP Ratio Rises to 82.5% in July, Above Forecast

Brazil’s gross government debt climbed to 82.5% of GDP in July, above the 82.2% market forecast and up from 81.9% in June. The ratio has risen steadily in recent months, increasing from 78.7% at the start of the year.

💬 🔗

The Investor 08-31-26

Brazil Unemployment Falls to 5.3% in July, Matching Expectations

Brazil’s unemployment rate declined to 5.3% in July from 5.4% previously, matching market expectations.

The decline points to continued resilience in Brazil’s labor market, with unemployment remaining at historically low levels.

💬 🔗

WS Investor 08-27-26

Brazil Inflation Eases to 4.44% in July, Slightly Above Forecast

Brazil’s annual consumer inflation slowed to 4.44% in July 2026, down from 4.64% in June, but came in slightly above the 4.40% market forecast.

The moderation brought inflation back inside the Brazilian central bank’s 1.5%-4.5% tolerance range around its 3% target. According to Reuters, lower food prices helped contain inflation, while housing costs, particularly electricity, remained a source of upward pressure.

💬 🔗

The Investor 08-11-26

Load More

07-10-25WS News

NASDAQ Follow

U.S. Stocks Mixed as Consumer Confidence Slumps and Job Openings Fall

U.S. stocks were mixed on Tuesday as fresh economic data pointed to softer consumer sentiment and a cooling labor market, while technology shares showed relative resilience.

The S&P 500 was little changed at 7,682.43, the Dow Jones Industrial Average fell 0.29% to 51,334.39, and the Nasdaq rose 0.18% to 26,867.67.

The biggest negative surprise came from consumer confidence. The Conference Board’s September index fell to 81.9 from 88.6, well below the 89.2 consensus estimate. The sharp drop suggests households are becoming more cautious about the economic outlook.

Labor-market data also softened. JOLTS job openings declined to 7.079 million in August from 7.335 million and missed expectations for 7.230 million, adding to signs that demand for workers is gradually cooling.

Housing data were more mixed. The S&P/Case-Shiller 20-city home price index was flat month over month in July, down from a 0.4% increase previously, while annual home-price growth accelerated to 2.5% from 2.2%, above expectations.

For markets, the combination of weaker confidence and lower job openings may support expectations for easier Federal Reserve policy over time. However, persistent home-price inflation and broader concerns around elevated inflation are keeping the policy outlook complicated, which helps explain the uneven performance across major indexes.

💬 🔗

WS News 09-29-26

U.S. Stocks Fall as Oil and Treasury Yields Rise, Reviving Inflation Concerns

U.S. stocks moved lower on Monday as rising oil prices pushed inflation expectations higher and drove Treasury yields back toward multi-decade highs, increasing pressure on equity valuations.

The S&P 500 fell 0.87% to 7,675.86, while the Dow Jones Industrial Average declined 0.63% to 51,503.20. The Nasdaq was the weakest of the major indexes, dropping 1.19% to 26,746.90 as higher bond yields weighed more heavily on technology and other long-duration growth stocks.

The main pressure came from energy markets. Brent crude rebounded as U.S.-Iran negotiations remained stalled and uncertainty over the Strait of Hormuz continued to threaten global supply flows. Higher oil prices are particularly important for equities because they can feed into transportation, production and consumer costs, making inflation harder to contain. (Market Screener)

Bond markets reflected those concerns. The U.S. 10-year Treasury yield climbed to about 5.26%, extending a sharp rise that has already taken yields to their highest levels in nearly two decades. Higher oil prices and stronger inflation expectations have contributed to expectations that the Federal Reserve may need to keep monetary policy tighter for longer.(FXStreet)

Inflation expectations had already been moving higher before Monday’s oil rebound. The University of Michigan’s September survey showed one-year inflation expectations rising to 4.6% from 4.0% in August, while five-year expectations edged up to 3.4% from 3.3%.

Other pressures are also weighing on sentiment. Investors are approaching a busy week of U.S. economic data, including the PCE inflation report and employment figures, while markets continue to assess the possibility of additional Federal Reserve tightening. Elevated government borrowing needs and concern over the U.S. fiscal outlook are also contributing to upward pressure on longer-term yields.

For equities, the combination is uncomfortable: higher oil prices raise inflation risks, higher inflation keeps pressure on the Fed, and higher Treasury yields increase the discount rate applied to future corporate earnings. That dynamic helps explain why the Nasdaq is underperforming the broader market in Monday trading.

💬 🔗

The Investor 09-28-26

U.S. Stocks Edge Lower as Jobless Claims Stay Low and Home Sales Beat Expectations

U.S. stocks traded modestly lower on Thursday, with the S&P 500 down 0.18% at 7,692.30, the Dow Jones falling 0.25% to 51,381.27 and the Nasdaq declining 0.53% to 26,792.15.

Fresh economic data pointed to continued resilience in parts of the U.S. economy. Initial jobless claims came in at 197,000, below the 201,000 expected and slightly below the previous 198,000, suggesting layoffs remain relatively contained. Continuing claims were 1.719 million, also below the 1.750 million forecast.

Housing data were also stronger than expected. August building permits were revised to 1.403 million from an earlier 1.394 million estimate, while new home sales reached 684,000, well above the 615,000 consensus and up from 643,000 previously.

The relatively firm labor and housing figures may be limiting expectations for faster Federal Reserve easing, putting some pressure on equities and particularly rate-sensitive technology shares. The Nasdaq was the weakest of the three major indexes in early trading.

💬 🔗

European Investor 09-24-26

U.S. Stocks Fall as Strong September PMI Data Revives Rate Concerns

U.S. stocks traded lower Tuesday as stronger-than-expected September business activity data raised concerns that resilient economic growth could keep interest rates elevated for longer.

The S&P 500 fell 0.37% to 7,736.24, while the Dow Jones Industrial Average declined 0.34% to 51,687.57. The Nasdaq underperformed with a 0.54% drop to 27,095.84.

S&P Global’s U.S. Manufacturing PMI jumped to 57.0 in September from 53.9, well above the 53.6 forecast. Services PMI also strengthened to 58.7 from 56.5, beating expectations of 55.8, while the Composite PMI climbed to 58.4 from 56.0.

The readings point to strong momentum across both manufacturing and services. While that supports the economic outlook, investors may also see the data as reducing the urgency for additional monetary easing and potentially keeping Treasury yields under upward pressure.

Technology stocks were among the weaker areas of the market, contributing to the Nasdaq’s larger decline. Investors will now watch upcoming inflation, labor-market and Federal Reserve signals for further clues on the path of interest rates.

💬 🔗

WS News 09-23-26

U.S. Stocks Mixed as Tech Gains Offset Dow Weakness, ADP Data Shows Firmer Hiring

U.S. stocks traded mixed Tuesday, with technology shares outperforming while the Dow Jones remained under pressure.

The S&P 500 was nearly flat, up 0.08% at 7,770.63. The Nasdaq gained 0.55% to 27,270.74, supported by strength in technology and growth stocks, while the Dow Jones fell 0.41% to 51,837.62.

Fresh labor-market data added a somewhat firmer signal to the session. ADP’s weekly employment estimate showed private-sector employment increased by 20,000, up from 16,300 previously. The improvement suggests hiring momentum remained positive, even as other recent indicators have pointed to some moderation in broader economic activity.

Investors are still balancing the Federal Reserve’s recent 25-basis-point rate increase against signs of softer growth. Flat August industrial production and a decline in the U.S. Leading Index have raised concerns about economic momentum, while the stronger ADP reading points to continued resilience in the labor market.

Lower oil prices are also helping ease inflation concerns, with Brent crude trading below $100 as Middle East supply fears moderate. That backdrop is supporting rate-sensitive growth stocks, particularly technology, while more cyclical Dow components remain weaker.

For now, the market is showing a clear divergence: technology shares continue to lead, while investors weigh resilient employment against tighter monetary policy and softer industrial indicators.

💬 🔗

WS Investor 09-22-26

U.S. Stocks Rally as AI Shares Surge and Falling Oil Prices Ease Inflation Fears

U.S. stocks traded sharply higher Monday, led by technology shares as falling oil prices and lower Treasury yields improved risk sentiment.

The S&P 500 rose 0.95% to 7,723.01, while the Dow Jones gained 0.43% to 51,903.85. The Nasdaq outperformed with a 1.53% advance to 26,927.20.

Technology and AI-related stocks were the main drivers of the rally. Chipmakers including AMD, Intel and Micron posted strong gains, while Meta also advanced as investors returned to AI-related names after last week’s concerns over the pace of artificial-intelligence development eased.

The broader market also benefited from a sharp decline in crude oil prices. Brent fell back toward $100 a barrel as concerns over Middle East supply disruptions eased, helping reduce inflation pressure and pushing the 10-year Treasury yield below 5%.

Improving U.S.-China sentiment added to the positive backdrop, with investors looking ahead to high-level discussions covering trade, technology and AI.

For now, the combination of lower energy prices, easing bond yields and renewed enthusiasm for AI is supporting a broad risk-on move, with the Nasdaq clearly leading the major U.S. indexes.

💬 🔗

The Investor 09-21-26

U.S. Stocks Slip as Weak Industrial Data and Higher Yields Offset Fed-Driven Optimism

U.S. stocks traded modestly lower Friday as investors weighed softer economic data against lingering confidence in the Federal Reserve’s inflation-fighting stance.

The S&P 500 fell 0.20% to 7,622.67, while the Dow Jones declined 0.34% to 51,602.07. The Nasdaq was down 0.13% at 26,383.07, giving back part of its earlier gains.

The session followed Thursday’s rally, when falling oil prices and lower long-term Treasury yields helped investors respond positively to the Fed’s 25-basis-point rate increase. The central bank raised its benchmark range to 3.75%–4.00%, and Chair Kevin Warsh emphasized that inflation remains too high, reinforcing confidence that the Fed is prepared to act against persistent price pressures.

Friday’s economic data were less supportive. U.S. industrial production was unchanged in August, missing expectations for a 0.3% increase, while manufacturing output fell 0.3% after seven consecutive monthly gains. The U.S. Leading Index also declined 0.1%, pointing to some moderation in near-term economic momentum.

At the same time, Treasury yields remained an important headwind. The 10-year yield has recently traded near 5%, keeping pressure on equity valuations, particularly in growth-sensitive sectors. Brent crude’s retreat below $100 has helped ease some inflation concerns, but investors remain focused on whether the Fed will deliver another rate increase later this year.

For now, Wall Street appears caught between confidence in the Fed’s inflation response and concern that tighter monetary policy, high yields and slowing industrial momentum could weigh on growth.

💬 🔗

WS Investor 09-18-26

U.S. Stocks Rally as Fed Rate Hike Boosts Confidence in Inflation Fight

U.S. stocks opened sharply higher Thursday, with investors responding positively to the Federal Reserve’s interest-rate decision and signs that policymakers remain committed to bringing inflation under control.

The S&P 500 rose 0.93% to 7,621.95, while the Dow Jones gained 0.52% to 51,730.65. The Nasdaq led the advance, climbing 1.28% to 26,312.06 as technology shares attracted renewed buying.

The gains followed Wednesday’s Federal Reserve decision to raise its benchmark rate by 25 basis points to a 3.75%–4.00% range. Although the move was widely expected, the unanimous decision under Fed Chair Kevin Warsh appeared to strengthen investor confidence that the central bank is prepared to address persistent inflation pressures.

Sentiment was also supported by a pullback in oil prices, easing some concerns that high energy costs could add further inflation pressure. Reuters reported that U.S. stock futures had already moved higher before the opening bell as lower crude prices reinforced the positive reaction to the Fed decision.

Still, the Fed maintained a hawkish stance, with most policymakers indicating that another rate increase could be appropriate before the end of the year. For now, however, markets appear to be focusing on the credibility of the Fed’s inflation response.

💬 🔗

WS News 09-17-26

U.S. Stocks Rise as Tech Gains Offset Fed Rate Concerns After Strong Retail Sales

U.S. stocks traded mostly higher Wednesday, with the S&P 500 up 0.37% to 7,613.62 and the Nasdaq gaining 0.69% to 26,160.05. The Dow Jones was nearly flat, slipping 0.08% to 52,048.87, as technology stocks led the market higher ahead of the Federal Reserve’s policy decision.

Fresh economic data showed that U.S. consumers remain surprisingly resilient. Retail sales jumped 1.2% month over month in August, beating the 0.8% forecast and reversing July’s 0.5% decline. Core retail sales were even stronger, rising 1.4% versus the 0.6% expected. The data adds to evidence that the U.S. economy continues to carry solid momentum.

The strength of consumer spending also complicates the interest-rate outlook. Markets are pricing a roughly 90% probability that the Fed will raise rates by 25 basis points later Wednesday, as policymakers confront persistent inflation and the inflationary impact of higher energy prices. The 10-year Treasury yield, which recently crossed 5% and reached its highest level since 2007, eased to around 4.97%, providing some relief for growth and technology stocks.

Oil prices also pulled back after their recent surge, with Brent falling around 1.5% today.

Investors are now focused on the Fed decision and Chair Kevin Warsh’s comments for clues on whether an expected rate increase represents a one-time response to renewed inflation pressures or the beginning of a broader tightening cycle.

💬 🔗

WS Investor 09-16-26

U.S. Stocks Fall as 10-Year Yield Hits 5% and Oil Fuels Fed Hike Fears

U.S. stocks traded lower Tuesday as surging Treasury yields, elevated oil prices and renewed geopolitical tensions outweighed signs of continued job creation.

The Dow Jones Industrial Average fell 0.96%, while the Nasdaq Composite declined 0.58% and the S&P 500 lost 0.44%. The benchmark 10-year U.S. Treasury yield climbed above 5%, reaching its highest level since 2007 as investors prepared for Wednesday’s Federal Reserve decision. Markets are pricing a roughly 90% probability of a 25-basis-point rate hike.

Economic data offered a mixed picture. Weekly ADP employment growth accelerated to 16,300 from 12,000, suggesting the labor market continues to add jobs. However, the New York Empire State Manufacturing Index dropped to 7.6 in September from 20.6, well below the 14.8 forecast.

Geopolitical risks remain another major headwind. Oil prices have stayed above $100 as renewed attacks involving Iran-aligned Houthis and Saudi Arabia increased concerns over Middle East supply disruptions. Higher energy prices are reinforcing inflation fears.

With bond yields around 5% increasing the relative attractiveness of fixed-income assets and putting pressure on equity valuations, investors are likely to remain cautious ahead of the Fed decision and its guidance on whether additional rate hikes could follow.

💬 🔗

The Investor 09-15-26

Load More

09-28-26WS News

09-25-26Global Finance News

09-15-26The Investor

09-14-26WS Investor

09-12-26WS News

NYSE:BACFollow

Track all markets on TradingView - Prices are not updated in real time

Bank of America and Bradesco Complete First Cross-Border Real-Time Payments Pilot

Bank of America said Bradesco has completed the first pilot transaction using its new Cross-Border Real-Time Payments solution, marking an early step in the bank’s effort to speed up international payments without requiring clients to replace their existing infrastructure.

The transaction was initiated through Bradesco’s existing Swift connectivity and delivered in Hong Kong dollars to a local beneficiary through Hong Kong’s Faster Payment System.

Bank of America designed the solution for high-volume, low-value payments, with features including real-time tracking, full-principal delivery and greater payment certainty. The bank also plans to make the capability available through CashPro, its digital banking platform for corporate and institutional clients.

The pilot is intended to show that banks can connect established payment channels such as Swift with domestic real-time payment networks, potentially improving speed and transparency for international transfers.

Bank of America and Bradesco are also testing a separate U.S. payment route through Swift aimed at improving consumer and small-business cross-border payments.

The development reflects Bank of America’s broader push to modernize global payments infrastructure while allowing financial institutions to maintain existing workflows and connectivity.

💬 🔗

WS Investor 09-29-26

Bank of America Expands AskGPS With New AI-Powered Treasury Intelligence Tools

Bank of America is expanding its internal Ask Global Payments Solutions platform with a new Intelligence Hub designed to help employees turn complex treasury data into more actionable client insights.

The new capabilities build on AskGPS, the bank’s generative AI application introduced in 2025 and already used by nearly 3,000 employees. The Intelligence Hub will bring together client, account and relationship data to give teams a more complete view of customer needs and help them prepare for treasury discussions more efficiently.

The first three tools will include Intelligent Treasury Management Reviews, Digital Account Schematics and Enhanced Relationship Insights. Together, they will help employees consolidate account structures, visualize liquidity and fund flows, identify changes in client relationships and surface potential gaps or opportunities.

Bank of America said the broader goal is to move from simple knowledge access toward “decision-ready intelligence,” allowing employees to get from questions to insights more quickly while keeping human judgment at the center of client interactions.

The expansion underscores how large banks are increasingly using generative AI not just for information retrieval, but to combine proprietary data and workflow context into tools that can support front-line decision making.

💬 🔗

European Investor 09-28-26

Bank of America’s CashPro App Tops €100 Billion in European Payment Approvals

Bank of America said European companies approved more than €100 billion in payments through its CashPro App during the first seven months of 2026, highlighting the growing adoption of mobile treasury tools across the region.

Transaction volume through the app rose 25% from a year earlier, while the value of payments increased 21%. Bank of America said mobile access is becoming increasingly embedded in corporate treasury workflows, particularly for secure authentication and payment approvals.

The bank said 74% of CashPro users in Europe now choose its mobile token as their preferred authentication method. The system combines mobile authentication with biometrics, QR sign-in and push authentication, allowing corporate treasury teams to approve transactions from mobile devices.

Bank of America has also enhanced the app’s payment approval experience and is developing new digital identity verification capabilities for corporate administrators.

CashPro is used by more than 35,000 companies globally to manage payments, deposits, loans and trade transactions. The platform also incorporates AI-powered tools for transaction support, capital-markets analysis and cash-flow forecasting.

💬 🔗

The Investor 09-17-26

Merrill Launches New Services for Tax-Efficient Portfolio Transitions and Cash Investing

Bank of America’s Merrill has launched two new investment services designed to help wealth-management clients transition portfolios and deploy cash more systematically.

The Tax Efficient Transition Service allows investors holding appreciated securities to gradually move assets into managed strategies rather than selling and reinvesting everything at once. The approach is intended to help clients manage the realization of capital gains while moving toward their target portfolio allocation.

Merrill also introduced a Dollar Cost Averaging Service, which automatically invests cash into eligible managed strategies according to a client-selected schedule. The service is designed to reduce the impact of short-term market volatility and encourage disciplined investing rather than attempting to time the market.

Both services combine automation with professional portfolio oversight and are available through the Merrill Lynch Investment Advisory Program without additional program fees.

💬 🔗

The Investor 09-15-26

Bank of America to Invest $1.9 Billion in Jio Credit, Expanding Its Position in India’s Financial Market

Bank of America (NYSE: BAC) is making a major push into India’s rapidly expanding consumer and commercial lending market through a new joint venture with Jio Financial Services.

Bank of America and Jio Financial Services announced Wednesday that they have signed a definitive agreement under which the U.S. banking giant will acquire up to a 49.9% interest in Jio Credit Limited, Jio Financial’s non-bank lending subsidiary. The investment, including equity shares and warrants, is valued at ₹18,268 crore, or approximately $1.9 billion.

## Bank of America Targets India’s Lending Growth

The transaction combines Jio Financial’s extensive digital reach and knowledge of the Indian market with Bank of America’s global financial-services, technology and risk-management capabilities.

Jio Credit has expanded rapidly since beginning operations. The digital-first non-bank financial company had assets under management of ₹30,667 crore, approximately $3.2 billion, as of June 30, 2026, reaching that scale within just two years. Its lending portfolio includes mortgages, loans against securities, commercial lending and supply-chain finance.

For Bank of America, the deal provides direct exposure to one of the world's fastest-growing major economies without requiring the bank to build a large domestic lending platform independently.

CEO Brian Moynihan described India as one of the world's most important growth markets and highlighted Jio Financial's ability to build more than $3 billion in assets under management in only two years.

## Jio Builds a Powerful Financial Services Ecosystem

The partnership also strengthens Jio Financial’s broader strategy of developing a full-scale digital financial-services ecosystem in India.

Jio Financial already operates across lending, payments, insurance and investment services. It has a 50:50 asset-management and wealth-management partnership with BlackRock and separate 50:50 insurance joint ventures with Allianz.

Adding Bank of America as a major partner in lending further strengthens that ecosystem and provides Jio Credit with additional capital to expand its loan portfolio.

Under the agreement, Jio Credit’s board will have equal representation from Jio Financial Services and Bank of America. Existing management will continue operating the business, while Jio Credit will remain consolidated as a Jio Financial subsidiary.

## Strategic Move for Both Companies

The $1.9 billion transaction is significant for Bank of America because it represents a substantial long-term commitment to India's financial sector rather than simply an expansion of its existing institutional banking operations.

For Jio Financial, the partnership provides both capital and access to Bank of America’s expertise in governance, technology, financial services and risk management as it scales its lending operations.

The deal also adds another major global financial institution to Jio Financial’s growing network of strategic partners. With BlackRock in investments, Allianz in insurance and now Bank of America in lending, Jio Financial is increasingly positioning itself as a broad-based digital financial-services platform in India.

💬 🔗

WS Investor 08-12-26

Bank of America (BAC) Stock Rises After Strong Q2 Results Fueled by Investment Banking and Trading Growth

Bank of America (NYSE: BAC) shares gained around 1% on Tuesday after the lender reported strong second-quarter 2026 results, with double-digit earnings growth driven by higher net interest income, booming investment banking activity, and record trading revenue.

The bank posted net income of $9.1 billion, up 27% year over year, while diluted earnings per share climbed 34% to $1.21. Revenue rose 15% to $31.6 billion, supported by a 9% increase in net interest income to $16.0 billion, stronger sales and trading performance, higher asset management fees, and robust investment banking revenue.

Bank of America's capital markets businesses delivered particularly strong results during the quarter. Investment banking fees jumped 50% from a year earlier, while sales and trading revenue increased 33%. Equity trading revenue surged 70%, and fixed income, currencies, and commodities (FICC) trading revenue rose 9%, benefiting from elevated client activity and stronger market conditions.

Consumer banking also remained resilient. Combined credit and debit card spending increased 9%, average deposits reached $957 billion, and the bank added more than 160,000 net new consumer checking accounts during the quarter. Assets under management and consumer investment assets also continued to grow, reflecting healthy client engagement.

Chairman and CEO Brian Moynihan said the company delivered one of its strongest quarters to date, highlighting double-digit net income growth across every business segment. He noted that resilient consumers and businesses continued to spend, borrow, and invest, while investment banking pipelines remain strong and commercial borrowing has begun to improve.

The solid earnings report reinforced investor confidence in Bank of America's diversified business model, with strength across consumer banking, wealth management, investment banking, and trading helping offset a still uncertain macroeconomic environment. Investors will now watch whether capital markets activity and loan growth remain supportive through the second half of 2026.

💬 🔗

The Investor 07-14-26

Bank of America Slips Despite Truist Price Target Increase

Bank of America (NYSE: BAC) shares slipped 0.5% on Friday even as Truist Financial raised its price target on the banking giant to $64 from $61, while maintaining a *Buy* rating.

The higher target reflects Truist's confidence in Bank of America's earnings outlook, supported by its strong consumer banking franchise, improving net interest income prospects, and resilient capital position. The reaffirmed Buy rating signals the firm's expectation that the bank remains well-positioned to benefit from a favorable operating environment.

Although the stock ended Friday slightly lower, the analyst's price target increase underscores continued optimism about Bank of America's long-term growth potential. With the new target implying meaningful upside from current levels, Wall Street remains constructive on the bank's outlook despite recent market weakness.

💬 🔗

The Investor 06-27-26

Bank of America Corporation today announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of $0.28 per share, payable on June 26, 2026 to shareholders of record as of June 5, 2026.

💬 🔗

Global Finance News 04-24-26

Bank of America Declares Preferred Stock Dividends Payable in May and June 2026

Bank of America Declares Preferred Stock Dividends Payable in May and June 2026. Details are at the link ...

(newsroom.bankofamerica.com)

💬 🔗

European Investor 04-18-26

Charlotte, April 15, 2026 — Bank of America reported first-quarter 2026 net income of $8.6 billion, with earnings per share rising 25% year-over-year to $1.11, supported by solid revenue growth and strong client activity.

Revenue increased 7% to $30.3 billion, driven by higher net interest income, which rose 9% to $15.7 billion, along with double-digit growth in trading, investment banking, and asset management fees. The bank highlighted continued momentum in consumer spending and stable asset quality, pointing to a resilient U.S. economy.

Across business segments, consumer banking generated $3.1 billion in profit on $11.0 billion in revenue, while global wealth and investment management earned $1.3 billion as client balances climbed to $4.6 trillion. Global banking delivered $2.1 billion in net income with investment banking fees up 21%, and global markets posted $2.0 billion in profit, supported by a 13% increase in trading revenue.

The bank maintained a strong balance sheet, with average deposits exceeding $2 trillion and loans growing 9% year-over-year. It returned $9.3 billion to shareholders through dividends and share buybacks during the quarter.

💬 🔗

WS Investor 04-16-26

Load More

04-15-26European Investor

04-15-26WS News

02-07-26WS News

01-26-26WS News

01-22-26WS News

NYSE:BRK.BFollow

Track all markets on TradingView - Prices are not updated in real time

Warren Buffett Becomes Berkshire Hathaway Chairman Emeritus as Howard Buffett Takes Chair Role

Berkshire Hathaway announced a major leadership transition Friday, naming Warren E. Buffett Chairman Emeritus while keeping him on the company’s board of directors. Howard G. Buffett, Warren Buffett’s son and a Berkshire director since 1993, was elected Chairman of the Board, while Susan Decker will remain Lead Independent Director.

The change separates Berkshire’s board leadership from day-to-day management. Greg Abel remains Chief Executive Officer and continues to run the company, while Howard Buffett will focus on preserving Berkshire’s culture and long-standing shareholder-oriented principles. In his shareholder letter, Warren Buffett said Abel has fully taken hold of the CEO role and that the timing was right to complete the transition.

Warren Buffett, who has led Berkshire for more than six decades, will continue to provide judgment and perspective as a director. The company described the move as consistent with its long-established succession planning. Berkshire’s 2026 filings already listed Greg Abel as President and CEO, with Warren Buffett serving as Chairman before Friday’s change.

Howard Buffett brings more than three decades of experience on Berkshire’s board and has served since 1999 as Chairman and CEO of the Howard G. Buffett Foundation.

The transition marks another major step in Berkshire’s post-Warren Buffett era, but the structure is designed to preserve continuity: Abel remains responsible for operations and capital allocation, Howard Buffett takes the board chairmanship, and Warren Buffett remains involved as Chairman Emeritus and director.

💬 🔗

Global Finance News 09-19-26

Taylor Morrison Soars 22% After Berkshire Hathaway Agrees to $8.5 Billion Acquisition

Shares of Taylor Morrison Home Corporation (NYSE: TMHC) surged 22% on Monday after the company announced that Berkshire Hathaway has agreed to acquire the homebuilder in an all-cash transaction valued at approximately $8.5 billion, marking one of the largest deals in the U.S. homebuilding sector in recent years. Source: Taylor Morrison Press Release, May 31, 2026.

Under the terms of the agreement, Berkshire Hathaway will pay $72.50 per share in cash for Taylor Morrison, representing a 24% premium to the company's May 29 closing price of $58.50. The transaction values Taylor Morrison's equity at approximately $6.8 billion and its enterprise value at roughly $8.5 billion. Source: Taylor Morrison Press Release, May 31, 2026.

The acquisition reflects Berkshire Hathaway's growing commitment to the U.S. housing market. Berkshire already owns major housing-related businesses, including Clayton Homes and numerous building products companies. Berkshire CEO Greg Abel described Taylor Morrison as a "best-in-class national homebuilder" and said the acquisition aligns with Berkshire's long-standing focus on housing and homeownership. Source: Taylor Morrison Press Release, May 31, 2026.

Investors welcomed the deal because it delivers immediate value and certainty to shareholders at a substantial premium. The purchase price effectively places a floor under the stock while reflecting Berkshire's confidence in the long-term outlook for U.S. housing despite elevated mortgage rates and economic uncertainty.

Taylor Morrison has grown into one of the largest homebuilders in the United States, operating more than 350 communities across 21 markets in 12 states. The company serves a broad range of customers through its Taylor Morrison and Esplanade brands and has expanded into build-to-rent communities through its Yardly platform. It also operates mortgage, title, escrow, and insurance businesses that complement its homebuilding operations. Source: Taylor Morrison Press Release, May 31, 2026.

Taylor Morrison Chairman and CEO Sheryl Palmer called the transaction a "once-in-a-lifetime opportunity," emphasizing that Berkshire's capital strength and long-term investment approach would allow the company to pursue growth opportunities that may not have been possible as a standalone public company. Importantly for investors and employees, Taylor Morrison's existing management team is expected to remain in place following the acquisition. Source: Taylor Morrison Press Release, May 31, 2026.

The deal also signals Berkshire Hathaway's continued willingness to deploy capital into sectors tied to long-term demographic and economic trends. While many investors associate Berkshire with insurance, railroads, and consumer brands, the company has steadily built a significant presence in residential housing. The addition of Taylor Morrison strengthens that position and creates the potential for greater coordination across Berkshire's existing homebuilding and construction-related businesses.

The transaction is expected to close during the second half of 2026, subject to shareholder approval and customary regulatory clearances. Once completed, Taylor Morrison will become a private company and its shares will no longer trade on the New York Stock Exchange. Source: Taylor Morrison Press Release, May 31, 2026.

For investors, the sharp rally reflects the market's assessment that Berkshire's offer provides an attractive exit price while validating the strength of Taylor Morrison's business model and long-term growth prospects.

💬 🔗

Global Finance News 06-02-26

The 'cash they have is excessive': Warren Buffett's exit puts spotlight on Berkshire Hathaway's next move

Warren Buffett has officially stepped down as CEO of Berkshire Hathaway. Investors are focused on what happens to the company's growing cash pile.

(finance.yahoo.com)

💬 🔗

WS News 01-04-26

VantagePoint Vantagepoint A.I. Hot Stocks Outlook for November 14, 2025 Stocks $ACHC, $HD, $LLY, $CLSK, $QQQ, $BRK/B

Hot stocks of the week ...

(vantagepointsoftware.com)

💬 🔗

The Investor 11-15-25

Berkshire Hathaway – Q3 2025 Earnings Rise to $30.8 Billion on Strong Operating Results

Berkshire Hathaway Inc. (NYSE: BRK.A, BRK.B) reported third-quarter 2025 net earnings of $30.8 billion, up from $26.3 billion a year earlier, driven by higher operating income and investment gains.

Operating earnings rose 34% year over year to $13.5 billion from $10.1 billion in Q3 2024, reflecting solid performances across insurance, rail, utilities, and manufacturing.
• Insurance underwriting income surged to $2.4 billion (up from $750 million).
• BNSF Railway earned $1.45 billion (up from $1.38 billion).
• Manufacturing, service, and retailing operations delivered $3.6 billion, up from $3.3 billion.
•
Investment gains totaled $17.3 billion, including $9.2 billion in unrealized gains.
For the first nine months of 2025, net earnings were $47.8 billion, compared with $69.3 billion in the same period last year, when results were inflated by large unrealized gains.

Insurance float stood at $176 billion as of September 30, 2025, up $5 billion since year-end 2024.

Berkshire emphasized that quarterly investment gains or losses can be “meaningless” for assessing performance, highlighting operating earnings as the best indicator of underlying business strength.

💬 🔗

Global Finance News 11-03-25

4 US Blue-Chips With Fortress Balance Sheets - The Smart Investor

4 US blue chips with ....

(thesmartinvestor.com.sg)

💬 🔗

The Investor 10-15-25

Berkshire Hathaway Separates Chairman and CEO Roles Ahead of Leadership Transition

Berkshire Hathaway Inc. (NYSE: BRK.A; BRK.B) announced that its board has amended and restated the company’s by-laws, effective September 30, 2025, to formally separate the roles of Chairman of the Board and Chief Executive Officer. The change comes in preparation for the transition on January 1, 2026, when Greg Abel will assume the role of President and CEO, succeeding Warren Buffett.

Buffett will remain Chairman of the Board, ensuring continuity of leadership, while Abel takes over day-to-day operations as CEO. The updated by-laws introduced a new provision under Section 3 for the Board of Directors and revised Section 4 relating to officers and agents to reflect the division of responsibilities.

💬 🔗

The Investor 10-03-25

Berkshire Hathaway announced it will acquire Occidental Petroleum’s chemical business, OxyChem, in a $9.7 billion all-cash deal. The agreement, unveiled on October 2, 2025, will make OxyChem an operating subsidiary of Berkshire, expanding its portfolio with a leading global manufacturer of commodity chemicals used in water treatment, pharmaceuticals, healthcare, and construction.

Occidental said it will use $6.5 billion of the proceeds to reduce debt, aiming to bring principal debt below $15 billion following its CrownRock acquisition. OxyChem’s environmental liabilities will remain with an Occidental subsidiary, which will continue to manage related remedial projects.

The transaction, subject to regulatory approvals, is expected to close in the fourth quarter of 2025. Occidental CEO Vicki Hollub praised the deal as strengthening the company’s financial position and long-term oil and gas strategy, while Berkshire’s Greg Abel highlighted the strong operating assets and workforce OxyChem brings to Berkshire’s non-insurance operations.

💬 🔗

WS Investor 10-02-25

Berkshire Hathaway Q2 Net Earnings Fall Amid Investment Swings; Operating Profit Stable

Berkshire Hathaway (NYSE: BRK.A, BRK.B) reported Q2 2025 net earnings of $12.4 billion, down sharply from $30.3 billion a year earlier, primarily due to lower investment gains and a $3.8 billion impairment on Kraft Heinz. However, operating earnings, which exclude market swings, held steady at $11.2 billion, versus $11.6 billion last year.

Key Figures:
• Net EPS: $8,601 for Class A; $5.73 for Class B
• Operating earnings: $11.2B in Q2; $20.8B in H1 2025 vs. $22.8B in H1 2024
• Insurance investment income rose to $3.37B
• BNSF railroad and energy businesses posted moderate gains
• Foreign currency losses totaled $877M in Q2

Investment results were volatile: Q2 included $4.2B in realized gains and $1.5B in unrealized gains, but H1 2025 saw a $5.9B net unrealized loss. Berkshire emphasized that investment fluctuations make net income less reflective of actual business performance.

Insurance float reached $174 billion, up $3B since year-end 2024.
Berkshire urged investors to consult its full 10-Q filing for deeper analysis.

💬 🔗

European Investor 08-05-25

Berkshire after Buffett: Can Greg Abel rise to the challenge?

The transition from Warren Buffett to Greg Abel represents less a reinvention than an evolution for Berkshire Hathaway.

(fifthperson.com)

💬 🔗

Global Finance News 05-27-25

Load More

09-29-26WS News

09-20-26WS News

08-20-26WS Investor

08-14-26Global Finance News

08-10-26The Investor

NYSE:MAFollow

Track all markets on TradingView - Prices are not updated in real time

Mastercard Launches AI-Powered B2B Analytics Platform for Commercial Payments

Mastercard has launched Advanced B2B Analytics, a new AI-powered platform designed to help banks and corporate customers identify supplier payment opportunities and expand commercial card usage.

The platform analyzes accounts payable data and uses AI-enabled acceptance propensity scoring to identify suppliers that are most likely to accept card payments. Users can also access interactive dashboards, working-capital insights and supplier prioritization tools intended to make commercial payment programs more targeted and efficient.

Mastercard said the product is aimed at a persistent problem in B2B payments: fragmented payment data and manual processes that make it difficult for issuers and corporate buyers to determine where card acceptance can create the most value.

For financial institutions, the platform is designed to support commercial card growth and deepen corporate relationships by helping clients optimize payment flows, improve supplier engagement and accelerate virtual card adoption. Mastercard estimates the addressable B2B payments opportunity at roughly $80 trillion.

Absa Group and Emirates NBD are among the first financial institutions to offer Advanced B2B Analytics to corporate clients.

The launch also fits Mastercard’s broader strategy of embedding AI, data and analytics more deeply into commercial payments. The company said Advanced B2B Analytics is the first foundational B2B capability in a wider effort to extend AI-driven intelligence across the supplier, issuer and acquirer sides of the payments ecosystem.

💬 🔗

WS Investor 09-29-26

Mastercard Stock Rises After Strong Q2 Results Beat Expectations

Mastercard (NYSE: MA) shares rose 1.3% in premarket trading on Thursday after the payments giant reported better-than-expected second-quarter results, driven by continued strength in consumer spending, cross-border transactions and its fast-growing value-added services business.

Second-quarter net revenue increased 14% year-over-year to $9.3 billion, while net income climbed 19% to $4.4 billion. Diluted earnings per share rose 22% to $4.97, with adjusted EPS reaching $5.04. The company also expanded its operating margin to 60.2%, reflecting strong operating leverage.

Payment Volumes and Cross-Border Spending Remain Strong

Mastercard continued to benefit from resilient global consumer spending. Gross dollar volume increased 8% on a local currency basis to $2.9 trillion, while purchase volume rose 10% and cross-border volume climbed 12%. Switched transactions, a key measure of network activity, increased 9% during the quarter.

Beyond traditional payment processing, the company's value-added services and solutions business grew 20%, supported by strong demand for cybersecurity, authentication, digital services and consumer engagement solutions, highlighting Mastercard's ongoing diversification beyond payment network fees.

Capital Returns Continue

Mastercard continued returning capital to shareholders, repurchasing $4.9 billion of stock during the second quarter while paying $771 million in dividends. The company still has $7.8 billion remaining under its current share repurchase authorization.

What to Watch

The strong premarket gain reflects investor confidence in Mastercard's ability to deliver consistent double-digit revenue growth despite an uncertain macroeconomic environment. Going forward, investors will watch trends in consumer spending, cross-border travel and the continued expansion of the company's higher-margin value-added services, which are becoming an increasingly important driver of long-term growth.

💬 🔗

WS Investor 07-30-26

Mastercard Slides 3% as April Spending Slowdown Overshadows a Strong Q1 Beat

Mastercard shares are down 3% in trading today, a classic case of strong results being punished by a weaker forward-looking indicator. The Q1 numbers themselves were impressive across the board, but April-to-date data showing a slowdown in cross-border volume growth is what markets are focused on.

Q1 net revenue rose 16% to $8.4 billion, beating estimates of $8.26 billion, while adjusted EPS of $4.60 topped the $4.41 consensus. Cross-border volume grew 13% on a local currency basis in the quarter, and switched transactions rose 9%. Value-added services and solutions, Mastercard's fastest-growing segment, delivered 22% revenue growth, driven by security, digital authentication and business insights products. (Yahoo Finance)

However, April-to-date transaction data showed a slowdown in cross-border activity, a key revenue driver, which is what sent shares lower despite the beat. The Iran war's dampening effect on international travel and global trade flows is the likely culprit, with cross-border volumes particularly sensitive to geopolitical disruption. (Trefis)

On the strategic front, CEO Michael Miebach pointed to two forward-looking initiatives: the rollout of Mastercard Agent Pay for agentic commerce and the planned acquisition of BVNK, a stablecoin infrastructure firm, for up to $1.8 billion, signaling the company's push into digital asset payments.

Mastercard repurchased 7.8 million shares at a cost of $4.0 billion in Q1 and paid $777 million in dividends, with $11.7 billion remaining under approved buyback programs. (Yahoo Finance)

💬 🔗

WS Investor 04-30-26

Mastercard to Acquire BVNK in $1.8 Billion Deal to Expand Digital Asset Payments

Mastercard announced an agreement to acquire stablecoin infrastructure provider BVNK for up to $1.8 billion, including contingent payments, as it expands its capabilities in digital assets and on-chain payments.

The acquisition will enable Mastercard to integrate stablecoins and tokenized deposits with traditional fiat payment rails, supporting use cases such as cross-border payments, remittances, and B2B transactions. The deal aims to enhance interoperability, speed, and programmability across payment systems, with closing expected by the end of the year pending regulatory approvals.
Business Wire

💬 🔗

WS Investor 03-17-26

Cloudflare, Inc. (NYSE: NET) and Mastercard Incorporated (NYSE: MA) announced a strategic partnership to expand cyber defense capabilities for small businesses, governments and critical infrastructure.

The collaboration will combine Mastercard’s Recorded Future and RiskRecon attack surface monitoring tools with Cloudflare’s Application Security portfolio. The joint solution is designed to help organizations identify unknown internet-facing assets, assess cyber posture in real time and automate remediation through controls such as web application firewalls and encryption.

Users will receive continuously updated security ratings, visibility into vulnerabilities and third-party risks, and prioritized remediation guidance within Cloudflare’s Security Insights dashboard.

The companies aim to close security gaps created by shadow IT, legacy systems and expanding digital ecosystems, providing smaller and resource-constrained organizations with enterprise-grade protection without slowing innovation.
Business Wire

💬 🔗

The Investor 02-17-26

Mastercard Incorporated reported strong fourth-quarter and full-year 2025 results, reflecting robust transaction growth, rising revenues, and continued momentum across its core payments and value-added services businesses.

In the fourth quarter, Mastercard posted net income of $4.1 billion, or $4.52 per diluted share. On an adjusted basis, net income reached $4.3 billion, with adjusted diluted EPS of $4.76. Net revenue rose 18% year over year to $8.8 billion, or 15% on a currency-neutral basis, supported by healthy consumer and business spending trends.

Operational metrics also showed solid growth. Gross dollar volume increased 7% on a local currency basis, while purchase volume rose 9%, underscoring sustained activity across global payment flows.

For full-year 2025, net revenue increased 16% year over year, or 15% on a currency-neutral basis. Management highlighted particularly strong performance in value-added services and solutions, which grew 23% for the year, as well as continued traction from strategic programs such as the Apple Card.

Chief Executive Officer Michael Miebach said the macroeconomic environment remained supportive throughout the year and emphasized that Mastercard’s focus on innovation, trusted technology, and deep partnerships positions the company well to capture further growth opportunities heading into 2026.

💬 🔗

Global Finance News 01-29-26

Mastercard announced the launch of Mastercard Agent Suite, a new set of services designed to help enterprises adopt agentic AI and integrate autonomous agents into their operations. The suite combines customizable AI agents with technical support and advisory services, leveraging Mastercard’s payments expertise, data insights, proprietary platforms and global advisor network.

Mastercard said the Agent Suite will enable businesses to build, test and deploy fit-for-purpose AI agents focused initially on use cases such as personalized product recommendations for banks and conversational shopping experiences for merchants. The offering is expected to be available in the second quarter of 2026 and will complement Mastercard’s broader AI and agentic commerce initiatives, with a strong emphasis on security, privacy and responsible AI design.

Source: Business Wire

💬 🔗

WS Investor 01-27-26

Mastercard Says U.S. Holiday Retail Sales Rose 3.9%

Mastercard SpendingPulse data shows U.S. retail sales excluding autos increased 3.9% year over year between November 1 and December 21, 2025, unadjusted for inflation. E-commerce sales rose 7.4%, while in-store sales grew 2.9%, highlighting continued omnichannel shopping. Apparel led category gains with a 7.8% increase, restaurant spending climbed 5.2%, and jewelry sales rose 1.6%. Mastercard noted that AI-driven personalization and inventory management increasingly shaped consumer shopping experiences.

Source: Mastercard via Business Wire

💬 🔗

Global Finance News 12-23-25

Mastercard launched **Mastercard Commerce Media**, a new digital media network leveraging its payments data and partnerships with Citi, WPP, Microsoft and American Airlines to deliver personalized advertising at scale, promising advertisers up to a 22-times return on ad spend while offering consumers more relevant content and brands stronger engagement.

💬 🔗

The Investor 10-01-25

Mastercard Launches AI-Powered Agentic Commerce Tools

Mastercard (NYSE: MA) unveiled new tools and partnerships with Stripe, Google, and Ant International to advance AI-driven payments. Its Agent Pay program will reach all U.S. cardholders before the holiday season, with a global rollout to follow, as the company pushes to set standards for trusted agentic transactions.

💬 🔗

The Investor 09-10-25

Load More

08-24-26European Investor

08-14-26Global Finance News

07-09-26WS News